Multiple myeloma is characterized by progressive immune dysfunction and multiple relapses, and off-the-shelf highly effective regimens are needed to fully address the needs of individual patients with relapsed or refractory multiple myeloma.

APhA Staff

Febrile neutropenia continues to challenge oncology teams despite decades of clinical experience.

Aiya Almogaber, PharmD

Cardiovascular disease is the leading cause of death in people with end-stage kidney disease, but there are few means of prevention.

Sonya Collins

Medication nonadherence remains a common challenge in patient care.

Emily Weyenberg, PharmD

Leaving a pharmacist out of a palliative care team is like trying to drive a car with a missing tire, said Rabia S. Atayee, PharmD.

Jen Hand